| Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||||||
Interest accrued on Investments Held in Trust Account | ||||||||||
3,909 | 3,370 | 2,758 | 2,136 | 1,625 | 1,152 | 642 | 306 | 0 | 0 | 0 |
Net income/(loss) attributable to ordinary shares | ||||||||||
- | - | 0 | 0 | - | - | -33 | -273 | 0 | 0 | 0 |
Changes in deferred offering costs associated with proposed offering | ||||||||||
- | - | - | - | - | - | - | - | - | - | 0 |
Changes in operating assets and liabilities | ||||||||||
Prepaid expenses | ||||||||||
-62 | -81 | -85 | -89 | -100 | 0 | 0 | 0 | - | - | - |
Accrued expenses | ||||||||||
5,259 | 5,523 | 1,299 | 257 | 25 | 48 | -13 | 117 | 0 | 0 | 0 |
Accrued interest | ||||||||||
16 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Cash flows from financing activities: | ||||||||||
Net cash used in operating activities | ||||||||||
- | - | - | 0 | - | - | - | -598 | 0 | 0 | 0 |
Due to related party | ||||||||||
- | 0 | 0 | 0 | - | 0 | 0 | 0 | - | - | - |
Loan from Sponsor | ||||||||||
2,000 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Proceeds from the sale of Class F ordinary shares to Sponsor | ||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 0 |
Proceeds of notes payable from Sponsor | ||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 0 |
Net cash provided by (used in) financing activities | ||||||||||
- | - | - | 0 | - | - | - | 251,226 | 0 | 0 | 0 |
Net increase (decrease) in cash | ||||||||||
- | - | - | 0 | - | - | - | 628 | 0 | 0 | 0 |